Michael Harrington, DPM
Podiatrist · North Attleboro, MANPI 1760971568
Payments from drug & device makers
What this record shows
25 manufacturers reported payments, led by Kairos Surgical Inc at 47.8% of the total. Reporting peaked in 2022 at $1,362 and has fallen 77.7% since, to $304 in 2025.
Across 53 payments — averaging $47.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kairos Surgical Inc$1K
- Stryker$177
- AstraZeneca$174
- Lilly USA, LLC$134
- Treace Medical Concepts, Inc.$127
- Bioventus LLC$82
- plus $632 from 19 others
What the payments were for
- Food & beverage$1,33853%
- Education$1,20047%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kairos Surgical Inc | 2 | $1,213 |
| Stryker | 2 | $177 |
| AstraZeneca | 9 | $174 |
| Lilly USA, LLC | 6 | $134 |
| Treace Medical Concepts, Inc. | 1 | $127 |
| Bioventus LLC | 3 | $82 |
| Philips North America LLC | 4 | $69 |
| Boehringer Ingelheim | 2 | $58 |
| Exact Sciences | 2 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $52 |
| Amgen | 2 | $47 |
| GSK | 2 | $47 |
| Novo Nordisk | 2 | $40 |
| Novus Surgical Consultants | 1 | $38 |
| Bayer | 2 | $36 |
| Grifols USA, LLC | 1 | $24 |
| Davol Inc. | 1 | $23 |
| Inogen, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $21 |
| Medtronic | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Sanofi-aventis U.S. LLC | 1 | $19 |
| Seqirus USA Inc | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,538 in reported general payments places this provider in the 75th percentile of 179 podiatrist providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 49 | $340 |
| Methylprednisolone | 16 | $146 |
| Cephalexin | 19 | $85 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $32 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in North Attleboro
- Pasquale CancelliereSomerville$374K
- Michael TheodoulouSomerville$210K
- Sara Rose-SauldWaltham$92K
- Jonathan KaplanWellesley$56K
- Thanh DinhBoston$48K
- Melissa RicciMilton$46K
- Jeffrey PantanoMilton$46K
- Barry RosenblumBoston$43K
- Louis DecaroWest Hatfield$19K
- Daren BergmanFramingham$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.